277 related articles for article (PubMed ID: 18359942)
1. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
Shah C; Yang G; Lee I; Bielawski J; Hannun YA; Samad F
J Biol Chem; 2008 May; 283(20):13538-48. PubMed ID: 18359942
[TBL] [Abstract][Full Text] [Related]
2. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
3. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.
Boini KM; Zhang C; Xia M; Poklis JL; Li PL
J Pharmacol Exp Ther; 2010 Sep; 334(3):839-46. PubMed ID: 20543095
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: involvement of intracellular ceramide signaling event.
Soeda S; Tsunoda T; Kurokawa Y; Shimeno H
Biochim Biophys Acta; 1998 Nov; 1448(1):37-45. PubMed ID: 9824663
[TBL] [Abstract][Full Text] [Related]
6. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
[TBL] [Abstract][Full Text] [Related]
7. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.
Morange PE; Lijnen HR; Alessi MC; Kopp F; Collen D; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1150-4. PubMed ID: 10764686
[TBL] [Abstract][Full Text] [Related]
8. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.
Ma LJ; Mao SL; Taylor KL; Kanjanabuch T; Guan Y; Zhang Y; Brown NJ; Swift LL; McGuinness OP; Wasserman DH; Vaughan DE; Fogo AB
Diabetes; 2004 Feb; 53(2):336-46. PubMed ID: 14747283
[TBL] [Abstract][Full Text] [Related]
9. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
10. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.
De Taeye BM; Novitskaya T; Gleaves L; Covington JW; Vaughan DE
J Biol Chem; 2006 Oct; 281(43):32796-805. PubMed ID: 16931518
[TBL] [Abstract][Full Text] [Related]
12. Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice.
Lallement J; Raho I; Merlen G; Rainteau D; Croyal M; Schiffano M; Kassis N; Doignon I; Soty M; Lachkar F; Krempf M; Van Hul M; Cani PD; Foufelle F; Amouyal C; Le Stunff H; Magnan C; Tordjmann T; Cruciani-Guglielmacci C
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Aug; 1868(8):159333. PubMed ID: 37224999
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.
Lijnen HR
Thromb Haemost; 2005 May; 93(5):816-9. PubMed ID: 15886793
[TBL] [Abstract][Full Text] [Related]
14. Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death.
Chi le NU; Tabuchi K; Nakamagoe M; Nakayama M; Nishimura B; Hara A
Arch Toxicol; 2015 Mar; 89(3):415-21. PubMed ID: 24798086
[TBL] [Abstract][Full Text] [Related]
15. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E211-24. PubMed ID: 19435851
[TBL] [Abstract][Full Text] [Related]
16. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
Baranowski M; Błachnio A; Zabielski P; Górski J
J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
[TBL] [Abstract][Full Text] [Related]
18. Daunorubicin attenuates tumor necrosis factor-alpha-induced biosynthesis of plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.
Soeda S; Iwata K; Hosoda Y; Shimeno H
Biochim Biophys Acta; 2001 Apr; 1538(2-3):234-41. PubMed ID: 11336794
[TBL] [Abstract][Full Text] [Related]
19. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
[TBL] [Abstract][Full Text] [Related]
20. Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.
Błachnio-Zabielska A; Zabielski P; Baranowski M; Gorski J
Lipids; 2011 Mar; 46(3):229-38. PubMed ID: 21181285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
